/ /

Christine Blank, Contributing Editor
Law Reauthorizes FDA Fees and Increases Access to Generics/Biosimilars
Senate passes FDARA overwhelmingly, ahead of September deadline.
Gottlieb Pushes for Generic Drug Access
Brand name drug companies are "gaming" the system, according to the FDA head.
Retailers and PBMs Laud Generic/Biosimilar Savings
Retailers and PBMs Laud Generic/Biosimilar Savings
Savings from generic and biosimilar drugs are making PBMs and pharmacies, as well as patients, happy.
Generics Savings Continue, but Work Remains
Generic drugs make up 90% of prescriptions.
Why Generic Drug Prices Are Dropping
Why Generic Drug Prices Are Dropping
Pharmacy chains are forcing lower generic prices for their customers.
Generic Cholesterol Meds a Boon for Patients
Two recent generic cholesterol-lowering drugs are helping reduce health-care costs.
Priority Generic Drugs to Get Faster FDA Review
FDA will shorten the review periods for priority generic drugs by two months.
Supreme Court Ruling Raises Biosimilars’ Access
High court ruling should make biosimilars available faster.
AAM Report on Generics Finds High Brand Abandonment Rate
Patients are less like to buy a requested brand name prescription than a generic one.
Pharmacist Intervention Improves Diabetes Drug Trials
Interventions by pharmacists can help improve the results of diabetes clinical trials.


View Results